PLA2G4D Protein (Myc-DYKDDDDK Tag)
-
- Target Alle PLA2G4D Produkte
- PLA2G4D (phospholipase A2, Group IVD (Cytosolic) (PLA2G4D))
- Protein-Typ
- Recombinant
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses PLA2G4D Protein ist gelabelt mit Myc-DYKDDDDK Tag.
- Applikation
- Antibody Production (AbP), Standard (STD)
- Produktmerkmale
-
- Recombinant human PLA2G4D protein expressed in HEK293 cells.
- Produced with end-sequenced ORF clone
- Reinheit
- > 80 % as determined by SDS-PAGE and Coomassie blue staining
-
-
- Applikationshinweise
-
Recombinant human proteins can be used for:
Native antigens for optimized antibody production
Positive controls in ELISA and other antibody assays - Kommentare
-
The tag is located at the C-terminal.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 50 μg/mL
- Buffer
- 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol.
- Lagerung
- -80 °C
- Informationen zur Lagerung
- Store at -80°C. Thaw on ice, aliquot to individual single-use tubes, and then re-freeze immediately. Only 2-3 freeze thaw cycles are recommended.
-
- Target
- PLA2G4D (phospholipase A2, Group IVD (Cytosolic) (PLA2G4D))
- Andere Bezeichnung
- Pla2g4d (PLA2G4D Produkte)
- Synonyme
- 2610311B01Rik Protein, Pla2delta Protein, cPLA2delta Protein, phospholipase A2, group IVD Protein, phospholipase A2 group IVD Protein, Pla2g4d Protein, PLA2G4D Protein
- Hintergrund
- The phospholipase A2 enzyme family, including PLA2G4D, catalyze the hydrolysis of glycerophospholipids at the sn-2 position and then liberate free fatty acids and lysophospholipids (Chiba et al., 2004 [PubMed 14709560]).[supplied by OMIM, Jun 2009].
- Molekulargewicht
- 91.8 kDa
- NCBI Accession
- NP_828848
- Pathways
- Inositol Metabolic Process, VEGF Signaling
-